Form 4: Autolus Therapeutics Director Acquires Shares
Insider Transaction Report
Ryan Richardson, a Director at Autolus Therapeutics plc, has acquired restricted stock units and share options.
Summary
- Ryan Richardson, a Director at Autolus Therapeutics plc (AUTL), reported a transaction on June 29, 2026.
- Richardson acquired 31,667 Restricted Stock Units (RSUs), which represent a contingent right to receive one share of the Issuer's American Depositary Shares.
- Additionally, Richardson acquired 47,500 share options, giving the right to buy American Depositary Shares at an exercise price of $1.61.
- The RSUs vest in one installment on June 29, 2027.
- The share options vest in twelve equal monthly installments starting July 29, 2026, with an expiration date of June 29, 2036.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it indicates a director's investment in the company, but it does not provide new financial information or strategic updates.
Positives
- Director acquisition of equity, indicating confidence in the company's future.
- Acquisition of both RSUs and share options, providing potential for future gains.
- Clear vesting schedules for both RSUs and options, offering transparency.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports on a director's acquisition of equity.
Industry Context
StockSavvy.ai notes that director acquisitions of equity, as reported in Form 4 filings, are common within the biotechnology and pharmaceutical sectors. Such transactions can signal insider confidence in the company's pipeline and future prospects, though they do not inherently guarantee performance.
Stakeholder Impact
- Shareholders may view the director's acquisition of equity positively, interpreting it as a sign of confidence in the company's long-term value.
Key Dates
| Date | Description |
|---|---|
| 06/29/2026 | Earliest transaction date and date of RSU acquisition and share option acquisition. |
| 07/29/2026 | Commencement date for monthly vesting of share options. |
| 06/29/2027 | Vesting date for Restricted Stock Units. |
| 06/29/2036 | Expiration date for share options. |
Keywords
Autolus Therapeutics, AUTL, Form 4, Insider Trading, Director, Restricted Stock Units, Share Options, Equity Acquisition, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.